C Ventures rebrands, hits first close on new fund
C Ventures, a VC firm set up by Adrian Cheng, scion of Hong Kong’s New World Development, has rebranded as C Capital – reflecting steps to diversify into a multi-strategy asset manager – and reached a first close on its latest fund.
The firm was founded in 2017, with its first fund acting essentially as a family office for Cheng. A second vehicle closed in 2019, attracting some third-party capital. Fund III has a target of USD 300m...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.